- Home
- ATNF vs NAOV Comparison
ATNF vs NAOV Comparison
Compare ATNF & NAOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNF
- NAOV
- Stock Information
- Founded
- ATNF 2016
- NAOV 2003
- Country
- ATNF United States
- NAOV United States
- Employees
- ATNF N/A
- NAOV N/A
- Industry
- ATNF Biotechnology: Pharmaceutical Preparations
- NAOV Industrial Specialties
- Sector
- ATNF Health Care
- NAOV Health Care
- Exchange
- ATNF Nasdaq
- NAOV Nasdaq
- Market Cap
- ATNF 1.8M
- NAOV 1.7M
- IPO Year
- ATNF N/A
- NAOV N/A
- Fundamental
- Price
- ATNF $1.42
- NAOV $0.50
- Analyst Decision
- ATNF
- NAOV
- Analyst Count
- ATNF 0
- NAOV 0
- Target Price
- ATNF N/A
- NAOV N/A
- AVG Volume (30 Days)
- ATNF 46.0K
- NAOV 45.9K
- Earning Date
- ATNF 11-07-2024
- NAOV 11-11-2024
- Dividend Yield
- ATNF N/A
- NAOV N/A
- EPS Growth
- ATNF N/A
- NAOV N/A
- EPS
- ATNF N/A
- NAOV N/A
- Revenue
- ATNF N/A
- NAOV $3,373,000.00
- Revenue This Year
- ATNF N/A
- NAOV N/A
- Revenue Next Year
- ATNF $54.15
- NAOV N/A
- P/E Ratio
- ATNF N/A
- NAOV N/A
- Revenue Growth
- ATNF N/A
- NAOV 424.57
- 52 Week Low
- ATNF $1.31
- NAOV $0.46
- 52 Week High
- ATNF $12.03
- NAOV $1.64
- Technical
- Relative Strength Index (RSI)
- ATNF 35.64
- NAOV 30.36
- Support Level
- ATNF $1.38
- NAOV $0.60
- Resistance Level
- ATNF $1.58
- NAOV $0.65
- Average True Range (ATR)
- ATNF 0.16
- NAOV 0.06
- MACD
- ATNF -0.05
- NAOV -0.02
- Stochastic Oscillator
- ATNF 4.60
- NAOV 14.37
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
About NAOV NanoVibronix Inc.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.